Lenalidomide might be a therapeutic strategy for isolated CNS relapse after HSCT and CAR-T cell therapy.
Keyphrases
- cell therapy
- acute lymphoblastic leukemia
- multiple myeloma
- stem cells
- mesenchymal stem cells
- newly diagnosed
- stem cell transplantation
- free survival
- hematopoietic stem cell
- allogeneic hematopoietic stem cell transplantation
- blood brain barrier
- chronic lymphocytic leukemia
- cerebrospinal fluid
- acute myeloid leukemia
- high dose
- replacement therapy